IMC Chicago LLC Buys Shares of 35,336 Haleon plc (NYSE:HLN)

IMC Chicago LLC purchased a new position in shares of Haleon plc (NYSE:HLN) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 35,336 shares of the company’s stock, valued at approximately $300,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Patrick M Sweeney & Associates Inc. bought a new position in Haleon in the fourth quarter valued at approximately $1,083,000. Wellington Management Group LLP raised its position in Haleon by 164.6% during the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after acquiring an additional 8,423,475 shares in the last quarter. Douglas Lane & Associates LLC lifted its stake in Haleon by 2.1% in the first quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock valued at $71,332,000 after acquiring an additional 175,082 shares during the last quarter. Optiver Holding B.V. grew its position in shares of Haleon by 223.0% in the 4th quarter. Optiver Holding B.V. now owns 1,008,565 shares of the company’s stock valued at $8,260,000 after acquiring an additional 696,327 shares during the period. Finally, Cambiar Investors LLC acquired a new position in shares of Haleon during the 4th quarter worth about $15,225,000. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HLN has been the subject of several recent analyst reports. HSBC assumed coverage on Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. Argus reissued a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. Finally, Berenberg Bank started coverage on Haleon in a report on Wednesday, June 5th. They set a “buy” rating for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Haleon Trading Down 2.0 %

Shares of HLN stock opened at $8.26 on Monday. Haleon plc has a 12-month low of $7.70 and a 12-month high of $8.96. The company has a market capitalization of $37.72 billion, a PE ratio of 27.53, a price-to-earnings-growth ratio of 2.19 and a beta of 0.26. The firm has a 50 day moving average price of $8.41 and a two-hundred day moving average price of $8.34. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53.

Haleon (NYSE:HLN) last released its quarterly earnings results on Wednesday, May 1st. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.01. The business had revenue of $3.70 billion during the quarter, compared to the consensus estimate of $3.71 billion. Haleon had a return on equity of 13.17% and a net margin of 9.68%. As a group, analysts predict that Haleon plc will post 0.46 earnings per share for the current year.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.